FDA Alignment to Advance ProstACT Global Phase 3 Trial

Go back to FDA Alignment to Advance ProstACT Global Phase 3 Trial
TRANS-LUX CORPORATION (NASDAQ: TLX) Delayed: 10.80 -0.08 (0.74%)
Previous Close $10.88    52 Week High $2.18 
Open $10.96    52 Week Low $0.30 
Day High $10.96    P/E N/A 
Day Low $10.73    EPS $-3.32 
Volume 146,589       

TRANS-LUX CORPORATION (NASDAQ: TLX) Delayed: 10.80 -0.08 (0.74%)
Previous Close $10.88    52 Week High $2.18 
Open $10.96    52 Week Low $0.30 
Day High $10.96    P/E N/A 
Day Low $10.73    EPS $-3.32 
Volume 146,589